Homozygosity for Pten in mice is embryonic lethal, but heterozygous Pten mice (Pten+/−) develop a variety of tumors including lymphomas, endometrial tumors, colon cancer, and gonadal tumors that are detectable between six months and one year of age [31], [39], [40]. This evidence concerns the gene PTEN and colonic neoplasm.